Cargando…
Role of N–epsilon- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus
PURPOSE: The aim of the present study was to evaluate the collective role of N-epsilon–carboxy methyl lysine (N(ε)-CML), advanced glycation end-products (AGEs), and reactive oxygen species (ROS) for the development of retinopathy among type 2 diabetic subjects. METHODS: Seventy type 2 diabetic subje...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559098/ https://www.ncbi.nlm.nih.gov/pubmed/23378723 |
_version_ | 1782257509200822272 |
---|---|
author | Choudhuri, Subhadip Dutta, Deep Sen, Aditi Chowdhury, Imran Hussain Mitra, Bhaskar Mondal, Lakshmi Kanta Saha, Avijit Bhadhuri, Gautam Bhattacharya, Basudev |
author_facet | Choudhuri, Subhadip Dutta, Deep Sen, Aditi Chowdhury, Imran Hussain Mitra, Bhaskar Mondal, Lakshmi Kanta Saha, Avijit Bhadhuri, Gautam Bhattacharya, Basudev |
author_sort | Choudhuri, Subhadip |
collection | PubMed |
description | PURPOSE: The aim of the present study was to evaluate the collective role of N-epsilon–carboxy methyl lysine (N(ε)-CML), advanced glycation end-products (AGEs), and reactive oxygen species (ROS) for the development of retinopathy among type 2 diabetic subjects. METHODS: Seventy type 2 diabetic subjects with nonproliferative diabetic retinopathy (NPDR), 105 subjects with proliferative diabetic retinopathy (PDR), and 102 patients with diabetes but without retinopathy (DNR) were enrolled in this study. In addition, 95 normal individuals without diabetes were enrolled as healthy controls in this study. Serum and vitreous N(ε)-CML and AGEs were measured by enzyme-linked immunosorbent assay. The peripheral blood mononuclear cell (PBMC) ROS level was measured by flow cytometric analysis. Serum and PBMC total thiols were measured by spectrophotometry. RESULTS: Serum AGEs and N(ε)-CML levels were significantly elevated in subjects with PDR (p<0.0001) and NPDR (p=0.0297 and p<0.0001, respectively) compared to DNR subjects. Further vitreous AGEs and N(ε)-CML levels were found to be significantly high among PDR subjects compared to the control group (p<0.0001). PBMC ROS production was found to be strikingly high among NPDR (p<0.0001) and PDR (p<0.0001) subjects as compared to the DNR group. Serum and PBMC total thiol levels were remarkably decreased in NPDR (p<0.0001 and p=0.0043, respectively) and PDR (p=0.0108 and p=0.0332 respectively) subjects than those were considered as DNR. CONCLUSIONS: Our findings suggest that N(ε)-CML and ROS are the key modulators for the development of nonproliferative retinopathy among poorly controlled type 2 diabetic subjects. Furthermore, AGEs under persistent oxidative stress and the deprived antioxidant state might instigate the pathogenic process of retinopathy from the nonproliferative to the proliferative state. |
format | Online Article Text |
id | pubmed-3559098 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Molecular Vision |
record_format | MEDLINE/PubMed |
spelling | pubmed-35590982013-02-01 Role of N–epsilon- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus Choudhuri, Subhadip Dutta, Deep Sen, Aditi Chowdhury, Imran Hussain Mitra, Bhaskar Mondal, Lakshmi Kanta Saha, Avijit Bhadhuri, Gautam Bhattacharya, Basudev Mol Vis Research Article PURPOSE: The aim of the present study was to evaluate the collective role of N-epsilon–carboxy methyl lysine (N(ε)-CML), advanced glycation end-products (AGEs), and reactive oxygen species (ROS) for the development of retinopathy among type 2 diabetic subjects. METHODS: Seventy type 2 diabetic subjects with nonproliferative diabetic retinopathy (NPDR), 105 subjects with proliferative diabetic retinopathy (PDR), and 102 patients with diabetes but without retinopathy (DNR) were enrolled in this study. In addition, 95 normal individuals without diabetes were enrolled as healthy controls in this study. Serum and vitreous N(ε)-CML and AGEs were measured by enzyme-linked immunosorbent assay. The peripheral blood mononuclear cell (PBMC) ROS level was measured by flow cytometric analysis. Serum and PBMC total thiols were measured by spectrophotometry. RESULTS: Serum AGEs and N(ε)-CML levels were significantly elevated in subjects with PDR (p<0.0001) and NPDR (p=0.0297 and p<0.0001, respectively) compared to DNR subjects. Further vitreous AGEs and N(ε)-CML levels were found to be significantly high among PDR subjects compared to the control group (p<0.0001). PBMC ROS production was found to be strikingly high among NPDR (p<0.0001) and PDR (p<0.0001) subjects as compared to the DNR group. Serum and PBMC total thiol levels were remarkably decreased in NPDR (p<0.0001 and p=0.0043, respectively) and PDR (p=0.0108 and p=0.0332 respectively) subjects than those were considered as DNR. CONCLUSIONS: Our findings suggest that N(ε)-CML and ROS are the key modulators for the development of nonproliferative retinopathy among poorly controlled type 2 diabetic subjects. Furthermore, AGEs under persistent oxidative stress and the deprived antioxidant state might instigate the pathogenic process of retinopathy from the nonproliferative to the proliferative state. Molecular Vision 2013-01-28 /pmc/articles/PMC3559098/ /pubmed/23378723 Text en Copyright © 2013 Molecular Vision. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Choudhuri, Subhadip Dutta, Deep Sen, Aditi Chowdhury, Imran Hussain Mitra, Bhaskar Mondal, Lakshmi Kanta Saha, Avijit Bhadhuri, Gautam Bhattacharya, Basudev Role of N–epsilon- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus |
title | Role of N–epsilon- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus |
title_full | Role of N–epsilon- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus |
title_fullStr | Role of N–epsilon- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus |
title_full_unstemmed | Role of N–epsilon- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus |
title_short | Role of N–epsilon- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus |
title_sort | role of n–epsilon- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559098/ https://www.ncbi.nlm.nih.gov/pubmed/23378723 |
work_keys_str_mv | AT choudhurisubhadip roleofnepsiloncarboxymethyllysineadvancedglycationendproductsandreactiveoxygenspeciesforthedevelopmentofnonproliferativeandproliferativeretinopathyintype2diabetesmellitus AT duttadeep roleofnepsiloncarboxymethyllysineadvancedglycationendproductsandreactiveoxygenspeciesforthedevelopmentofnonproliferativeandproliferativeretinopathyintype2diabetesmellitus AT senaditi roleofnepsiloncarboxymethyllysineadvancedglycationendproductsandreactiveoxygenspeciesforthedevelopmentofnonproliferativeandproliferativeretinopathyintype2diabetesmellitus AT chowdhuryimranhussain roleofnepsiloncarboxymethyllysineadvancedglycationendproductsandreactiveoxygenspeciesforthedevelopmentofnonproliferativeandproliferativeretinopathyintype2diabetesmellitus AT mitrabhaskar roleofnepsiloncarboxymethyllysineadvancedglycationendproductsandreactiveoxygenspeciesforthedevelopmentofnonproliferativeandproliferativeretinopathyintype2diabetesmellitus AT mondallakshmikanta roleofnepsiloncarboxymethyllysineadvancedglycationendproductsandreactiveoxygenspeciesforthedevelopmentofnonproliferativeandproliferativeretinopathyintype2diabetesmellitus AT sahaavijit roleofnepsiloncarboxymethyllysineadvancedglycationendproductsandreactiveoxygenspeciesforthedevelopmentofnonproliferativeandproliferativeretinopathyintype2diabetesmellitus AT bhadhurigautam roleofnepsiloncarboxymethyllysineadvancedglycationendproductsandreactiveoxygenspeciesforthedevelopmentofnonproliferativeandproliferativeretinopathyintype2diabetesmellitus AT bhattacharyabasudev roleofnepsiloncarboxymethyllysineadvancedglycationendproductsandreactiveoxygenspeciesforthedevelopmentofnonproliferativeandproliferativeretinopathyintype2diabetesmellitus |